Interferon gamma (IFNγ) is a central cytokine in human defense against intracellular microbes, but the pathways by which specific interferon-stimulated genes effect cell-intrinsic protection remain incompletely defined. The authors report an intracellularly acting cytokine, IL32, that executes a surveillance and effector program to target and restrict vacuolar pathogens. The work positions IL32 as a molecular bridge between IFNγ signaling and selective autophagic elimination of pathogen-containing vacuoles, a process often termed xenophagy.
The findings are reported in a bioRxiv preprint and have not been certified by peer review.
To uncover factors required for IL32-dependent targeting, the investigators combined quantitative proteomics with a focused CRISPR genetic screen. These complementary approaches converged on components of the cysteine/Arg N-degron pathway as modifiers of IL32. The N-degron pathway is implicated in post-translational modification and regulated proteolysis; in this study it is reported to act on IL32 in a manner that enables downstream antimicrobial activity.
The source indicates that specific proteins from this degradation/recognition pathway were detected as interacting or functionally required in the screens, linking the pathway to IL32-dependent host defense. Exact proteomic hits, CRISPR target lists, and statistical details are provided in the full preprint but are not exhaustively recapitulated here.
The authors describe a biochemical sequence in which IL32 undergoes oxidation-dependent arginylation, a modification mediated by the cysteine/Arg N-degron machinery. This arginylation of IL32 purportedly licenses the recruitment of the autophagy apparatus to pathogen-containing vacuoles, enabling xenophagic capture and restriction of the intravacuolar microbes.
By connecting a post-translational arginylation event to autophagy recruitment, the report defines an intracellular sensing and effector axis: IFNγ induces or primes the system, IL32 is modified by N-degron pathway components via oxidation and arginylation, and autophagy machinery is subsequently recruited to execute xenophagic clearance. The abstract highlights this sequence without reporting the full biochemical kinetics, dose–response relationships, or the precise autophagy receptor molecules involved; those experimental data are referenced in the preprint.
The IL32-dependent mechanism is reported to act against phylogenetically distinct vacuolar pathogens, specifically the bacterium Chlamydia and the microsporidian Encephalitozoon. Both organisms replicate within membrane-bound vacuoles in host cells, and the study shows that IL32 targeting restricts these pathogens through recruitment of autophagy to their vacuoles.
The preprint frames these organisms as representative vacuolar pathogens and presents IL32-mediated xenophagy as a broadly relevant antiviral/antiparasitic axis; however, the abstract does not enumerate the full pathogen spectrum tested, experimental models, or quantitative reductions in pathogen burden. Those methodological and quantitative details are available in the full manuscript.
To define microbial strategies that counteract IL32-mediated surveillance, the authors performed a forward genetics screen in Chlamydia trachomatis, a leading cause of bacterial sexually transmitted infection. This genetic screen identified a secreted virulence factor, IncS, as an evasion determinant that blocks IL32 targeting of the bacterial vacuole.
IncS is reported to shield C. trachomatis from xenophagy by interfering with IL32-dependent recruitment of autophagy machinery. The identification of IncS as an evasion factor provides a functional counterpoint that supports the biological relevance of the IL32–N-degron–autophagy axis in host–pathogen conflict. The abstract does not provide the detailed mutational map, mechanism of IncS action at molecular resolution, or whether IncS has additional roles in pathogenesis; such specifics are described in the primary preprint.
Collectively, the study establishes an IL32-dependent intracellular sensing mechanism that connects IFNγ signaling to N-degron–mediated xenophagy. By showing that post-translational modification of IL32 via oxidation-dependent arginylation is required for recruitment of autophagy to pathogen-containing vacuoles, the work reveals a previously underappreciated axis of human cell-autonomous immunity.
The demonstration that a bacterial virulence factor, IncS, can block this pathway highlights an active evolutionary conflict and suggests that pathogens evolved specific countermeasures to evade IL32-dependent xenophagy.
Because this report is a preprint, the results should be interpreted with the consideration that they have not undergone peer review. The abstract summarizes the core discoveries—IL32 as an intracellular effector, involvement of the cysteine/Arg N-degron pathway, oxidation-dependent arginylation, autophagy recruitment, activity against Chlamydia and Encephalitozoon, and identification of IncS as an evasion factor—while additional experimental details and full data are available in the complete manuscript and supplementary materials.
These findings prompt several avenues for follow-up: mapping the molecular interfaces between IL32, the N-degron machinery, and autophagy receptors; assessing the breadth of pathogens susceptible to this axis; determining in vivo relevance in human-relevant models; and exploring whether modulation of this pathway could be therapeutically exploitable to bolster cell-autonomous defenses.